Cevey, Maria
33  Ergebnisse:
Personensuche X
?
2

Budget Impact Analysis Of Subcutaneous Belimumab In Patient..:

Cevey, Maria ; Calvo-Alén, Jaime ; Crespo, Carlos...
ClinicoEconomics and Outcomes Research.  11 (2019)  - p. 757-765 , 2019
 
?
3

Budget Impact Analysis Of Subcutaneous Belimumab In Patient..:

Cevey, Maria ; Calvo-Alén, Jaime ; Crespo, Carlos...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CEOR.S218464.  , 2019
 
?
4

Budget impact analysis of Subcutaneous Belimumab in patient..:

Cevey, María ; Calvo-Alén, Jaime ; Crespo Palomo, Carlos...
Reproducció del document publicat a: https://doi.org/10.2147/CEOR.S218464.  , 2019
 
?
7

Studies on the contribution of PPAR Gamma to tuberculosis p..:

Díaz, Ariana ; D'Attilio, Luciano ; Penas, Federico...
Frontiers in Cellular and Infection Microbiology.  13 (2023)  - p. , 2023
 
?
10

Treatment in vitro with PPARα and PPARγ ligands drives M1-t..:

Penas, Federico ; Mirkin, Gerardo A. ; Vera, Marcela...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.  1852 (2015)  5 - p. 893-904 , 2015
 
?
11

PPARγ ligand treatment inhibits cardiac inflammatory mediat..:

Penas, Federico ; Mirkin, Gerardo A. ; Hovsepian, Eugenia...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.  1832 (2013)  1 - p. 239-248 , 2013
 
?
14

Treatment with Fenofibrate plus a low dose of Benznidazole ..:

Cevey, Ágata C. ; Mirkin, Gerardo A. ; Donato, Martín...
International Journal for Parasitology: Drugs and Drug Resistance.  7 (2017)  3 - p. 378-387 , 2017
 
1-15